Esophageal squamous cell carcinoma tissue microarray, containing 35 cases of squamous cell carcinoma, single core per case. Pathology grade, TNM Classification and Clinical stage information available.
Price
$140.00
Catalogue No | ES351 |
Description | Esophageal squamous cell carcinoma tissue microarray, containing 35 cases of squamous cell carcinoma, single core per case. Pathology grade, TNM Classification and Clinical stage information available. |
Species | Human |
Fixative | Formalin |
Total Cases | 35 |
Total Cores | 35 |
Core Diameter | 2 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | ES | ES | ES | ES | ES | ES | ES | |||||||||||||||||||||||||||||||||||||
B | ES | ES | ES | ES | ES | ES | ES | |||||||||||||||||||||||||||||||||||||
C | ES | ES | ES | ES | ES | ES | ES | |||||||||||||||||||||||||||||||||||||
D | ES | ES | ES | ES | ES | ES | ES | |||||||||||||||||||||||||||||||||||||
E | ES | ES | ES | ES | ES | ES | ES | |||||||||||||||||||||||||||||||||||||
N | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 58 | F | Esophagus | Squamous cell carcinoma | 1 | T1N0M0 | IA | Malignant |
2 | A2 | 64 | F | Esophagus | Squamous cell carcinoma | 1 | T2N0M0 | IB | Malignant |
3 | A3 | 75 | M | Esophagus | Squamous cell carcinoma | 1 | T2N0M0 | IB | Malignant |
4 | A4 | 55 | M | Esophagus | Squamous cell carcinoma | 1 | T2N0M0 | IB | Malignant |
5 | A5 | 69 | F | Esophagus | Squamous cell carcinoma | 1 | T2N0M0 | IIA | Malignant |
6 | A6 | 53 | F | Esophagus | Squamous cell carcinoma | 1 | T2N0M0 | IIA | Malignant |
7 | A7 | 70 | F | Esophagus | Squamous cell carcinoma | - | T2N0M0 | IIA | Malignant |
8 | B1 | 71 | M | Esophagus | Squamous cell carcinoma | 1 | T2N0M0 | IIA | Malignant |
9 | B2 | 48 | M | Esophagus | Squamous cell carcinoma | 1 | T2N0M0 | IIA | Malignant |
10 | B3 | 42 | M | Esophagus | Squamous cell carcinoma | 1 | T2N0M0 | IIA | Malignant |
11 | B4 | 52 | M | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
12 | B5 | 54 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
13 | B6 | 55 | M | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
14 | B7 | 56 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
15 | C1 | 68 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
16 | C2 | 66 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
17 | C3 | 59 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
18 | C4 | 50 | M | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
19 | C5 | 54 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
20 | C6 | 45 | M | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
21 | C7 | 58 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
22 | D1 | 58 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
23 | D2 | 71 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
24 | D3 | 61 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
25 | D4 | 63 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
26 | D5 | 34 | M | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
27 | D6 | 63 | M | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
28 | D7 | 49 | M | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
29 | E1 | 52 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
30 | E2 | 63 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
31 | E3 | 58 | M | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
32 | E4 | 61 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
33 | E5 | 60 | M | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
34 | E6 | 60 | F | Esophagus | Squamous cell carcinoma | 1 | T3N0M0 | IIA | Malignant |
35 | E7 | 54 | M | Esophagus | Squamous cell carcinoma | 1 | T1N1M0 | IIB | Malignant |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |